The trademark TYGOVY was filed by Foresee Pharmaceuticals Co., Ltd., a corporation established under the laws of Taiwan, Republic of China (the "Applicant"). The application was published for oppositions on September 3, 2020, and received one opposition filed on December 3, 2020 by Immunomedics, Inc. on Likelihood of confusion. the opponent was represented by FRKelly and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 3, 2020
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).